Age-Related Changes in HAPLN1 Increase Lymphatic Permeability and Affect Routes of Melanoma Metastasis
Open accessPublished version of a preprint
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Older patients with melanoma have lower rates of sentinel lymph node (LN) metastases yet paradoxically have inferior survival. Patient age correlated with an inability to retain Technetium radiotracer during sentinel LN biopsy in more than 1,000 patients, and high Technetium counts correlated to better survival. We hypothesized that loss of integrity in the lymphatic vasculature due to extracellular matrix (ECM) degradation might play a role. We have implicated HAPLN1 in age-dependent ECM degradation in the dermis. Here, we queried whether HAPLN1 could be altered in the lymphatic ECM. Lymphatic HAPLN1 expression was prognostic of long-term patient survival. Adding recombinant HAPLN1 to aged fibroblast ECMs in vitro reduced endothelial permeability via modulation of VE-cadherin junctions, whereas endothelial permeability was increased following HAPLN1 knockdown in young fibroblasts. In vivo, reconstitution of HAPLN1 in aged mice increased the number of LN metastases, but reduced visceral metastases. These data suggest that age-related changes in ECM can contribute to impaired lymphatics. Significance: Our studies reveal that changes in the stroma during aging may influence the way tumor cells traffic through the lymphatic vasculature. Aging may dictate the route of metastatic dissemination of tumor cells, and understanding these changes may help to reveal targetable moieties in the aging tumor microenvironment. See related commentary by Marie and Merlino, p. 19. This article is highlighted in the In This Issue feature, p. 1
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As shown in Fig. 5, the loose arrangement of the ECM in the aging microenvironment may be one of the causes of metastasis in elderly patients with tumors [69, 70].”
From Immunosenescence: a key player in cancer development (2020) · cites this paper as [69]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In normal development and physiology, fibroblasts are the major producers of connective tissue ECM, with emerging data indicating that this function is modified with age9,10.”
From A framework for advancing our understanding of cancer-associated fibroblasts (2020) · cites this paper as [9]
Experimental — accuracy not yet measuredIn the citing paper
“Compared with young patients with melanoma, ECM rearrangement resulting from Hyaluronan And Proteoglycan Link Protein 1 changes in elderly patients can cause melanoma cells to be more invasive and prone to distant metastasis [69].”
From Immunosenescence: a key player in cancer development (2020) · cites this paper as [69]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kaur, A., Webster, M. R., Marchbank, K., Behera, R., Ndoye, A., Kugel, C. H., Dang, V. M., Appleton, J., O’Connell, M. P., Cheng, P., et al. (2016) · Nature · doi:10.1038/nature17392 · Cited by 398 · cited 2×
“In direct support, aged mice have higher expression of sFRP2 than young mice and are more likely to develop tumors with a higher density of CD31-positive vessels (26), providing a mechanism by which tumor cells may reach visceral sites independent of the age-related changes in lymphatic permeability.”
BackgroundSelf-citationRetractedAmin, M. B., Greene, F. L., Edge, S. B., Compton, C. C., Gershenwald, J. E., Brookland, R. K., Meyer, L., Gress, D. M., Byrd, D. R., & Winchester, D. P. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21388 · Cited by 6,502
Genomic classification of cutaneous melanoma
Akbani, R., Akdemir, K. C., Aksoy, B. A., Albert, M., Ally, A., Amin, S. B., Arachchi, H., Arora, A., Auman, J. T., Ayala, B., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.044 · Cited by 3,151
Balch, C. M., Soong, S.-J., Gershenwald, J. E., Thompson, J. F., Reintgen, D. S., Cascinelli, N., Urist, M., McMasters, K. M., Ross, M. I., Kirkwood, J. M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3622 · Cited by 2,388 · cited 1×
“The progression of cancer to distant metastatic sites is the single most prognostic factor for many solid organ malignancies (1, 2).”
BackgroundFinal Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma
Morton, D. L., Thompson, J. F., Cochran, A. J., Mozzillo, N., Nieweg, O. E., Roses, D. F., Hoekstra, H. J., Karakousis, C. P., Puleo, C. A., Coventry, B. J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1310460 · Cited by 1,484 · cited 1×
“Yet, the lack of survival benefit following lymphadenectomy in patients with melanoma has inspired the alternate view that lymphatic and visceral metastases develop independently (25).”
BackgroundSelf-citationCompletion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
Faries, M. B., Thompson, J. F., Cochran, A. J., Andtbacka, R. H., Mozzillo, N., Zager, J. S., Jahkola, T., Bowles, T. L., Testori, A., Beitsch, P. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1613210 · Cited by 1,414
Self-citationBrafV600E cooperates with Pten loss to induce metastatic melanoma
Dankort, D., Curley, D. P., Cartlidge, R. A., Nelson, B., Karnezis, A. N., Damsky Jr, W. E., You, M. J., DePinho, R. A., McMahon, M., & Bosenberg, M. (2009) · Nature Genetics · doi:10.1038/ng.356 · Cited by 1,189
VE-Cadherin and Endothelial Adherens Junctions: Active Guardians of Vascular Integrity
Giannotta, M., Trani, M., & Dejana, E. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.08.020 · Cited by 854 · cited 1×
“VE-cadherin is a critical component of endothelial adherens junctions and mediates vessel permeability (20).”
BackgroundMetastatic pattern of malignant melanoma
Patel, J. K., Didolkar, M. S., Pickren, J. W., & Moore, R. H. (1978) · The American Journal of Surgery · doi:10.1016/0002-9610(78)90171-x · Cited by 641 · cited 1×
“The sequential cascade model is supported by clinical observation, particularly that the development of lymphatic disease often precedes distant metastasis (23, 24).”
BackgroundInsights into the mechanisms of lymph node metastasis
Nathanson, S. D. (2003) · Cancer · doi:10.1002/cncr.11464 · Cited by 433 · cited 1×
“Melanoma cells travel via afferent lymphatic vessels to enter the subcapsular sinus of lymph nodes (18).”
Background
Cited by
A framework for advancing our understanding of cancer-associated fibroblasts
Sahai, E., Astsaturov, I., Cukierman, E., DeNardo, D. G., Egeblad, M., Evans, R. M., Fearon, D., Greten, F. R., Hingorani, S. R., Hunter, T., et al. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0238-1 · Cited by 3,863
Self-citationMolecular principles of metastasis: a hallmark of cancer revisited
Fares, J., Fares, M. Y., Khachfe, H. H., Salhab, H. A., & Fares, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0134-x · Cited by 2,379
Concepts of extracellular matrix remodelling in tumour progression and metastasis
Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J., & Werb, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-18794-x · Cited by 2,296
Cox, T. R. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00329-7 · Cited by 976
Immunosenescence: molecular mechanisms and diseases
Liu, Z., Liang, Q., Ren, Y., Guo, C., Ge, X., Wang, L., Cheng, Q., Luo, P., Zhang, Y., & Han, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01451-2 · Cited by 960
“Compared with young melanoma patients, ECM changes in elderly patients result in lower sentinel lymph node metastasis rates but higher mortality.(188) Studies have suggested that slower tumor growth and metastasis in elderly patients with bronchial cancer are due to senescent host factors hindering the growth and spre…”
How the ageing microenvironment influences tumour progression
Fane, M., & Weeraratna, A. T. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0222-9 · Cited by 849
Self-citationMonteran, L., & Erez, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01835 · Cited by 675
Immunosenescence: a key player in cancer development
Lian, J., Yue, Y., Yu, W., & Zhang, Y. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00986-z · Cited by 510
Metastasis-Initiating Cells and Ecosystems
Massagué, J., & Ganesh, K. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0010 · Cited by 372
Tumor-draining lymph nodes: At the crossroads of metastasis and immunity
du Bois, H., Heim, T. A., & Lund, A. W. (2021) · Science Immunology · doi:10.1126/sciimmunol.abg3551 · Cited by 323
Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies
Mhaidly, R., & Mechta-Grigoriou, F. (2020) · Seminars in Immunology · doi:10.1016/j.smim.2020.101417 · Cited by 259
Mhaidly, R., & Mechta‐Grigoriou, F. (2021) · Immunological Reviews · doi:10.1111/imr.12978 · Cited by 231
The current paradigm and challenges ahead for the dormancy of disseminated tumor cells
Risson, E., Nobre, A. R., Maguer-Satta, V., & Aguirre-Ghiso, J. A. (2020) · Nature Cancer · doi:10.1038/s43018-020-0088-5 · Cited by 230
Stromal changes in the aged lung induce an emergence from melanoma dormancy
Fane, M. E., Chhabra, Y., Alicea, G. M., Maranto, D. A., Douglass, S. M., Webster, M. R., Rebecca, V. W., Marino, G. E., Almeida, F., Ecker, B. L., et al. (2022) · Nature · doi:10.1038/s41586-022-04774-2 · Cited by 179
Self-citationElgundi, Z., Papanicolaou, M., Major, G., Cox, T. R., Melrose, J., Whitelock, J. M., & Farrugia, B. L. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01482 · Cited by 176
“A series of recent studies (40, 41) demonstrated that the ECM molecule hyaluronan and proteoglycan link protein-1 (HAPLN1) decreased with aging of the ECM.”
BackgroundDieterich, L. C., Tacconi, C., Ducoli, L., & Detmar, M. J. (2022) · Physiological Reviews · doi:10.1152/physrev.00039.2021 · Cited by 181
Zhang, T., Li, X., He, Y., Wang, Y., Shen, J., Wang, S., You, Q., Zhai, J., & Shen, L. (2021) · Gastric Cancer · doi:10.1007/s10120-021-01259-5 · Cited by 142
Unraveling the ECM-Immune Cell Crosstalk in Skin Diseases
Bhattacharjee, O., Ayyangar, U., Kurbet, A. S., Ashok, D., & Raghavan, S. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00068 · Cited by 119
The Role of the ECM in Lung Cancer Dormancy and Outgrowth
Parker, A. L., & Cox, T. R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01766 · Cited by 103
“Age-related loss of the hyaluronan and proteoglycan link protein 1 (HAPLN1), which directly binds hyaluronan (120), has also been associated with increased lymph node permeability and increased lymphatic metastasis in melanoma (121, 122).”
BackgroundDevelopment and aging of the lymphatic vascular system
González-Loyola, A., & Petrova, T. V. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.005 · Cited by 89
Melanoblast transcriptome analysis reveals pathways promoting melanoma metastasis
Marie, K. L., Sassano, A., Yang, H. H., Michalowski, A. M., Michael, H. T., Guo, T. W., Tsai, Y. C., Weissman, A. M., Lee, M. P., Jenkins, L. M. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14085-2 · Cited by 94
The fibrotic and immune microenvironments as targetable drivers of metastasis
Boulter, L., Bullock, E., Mabruk, Z., & Brunton, V. G. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01172-1 · Cited by 82
“Secretion of hyaluronic and proteoglycan link protein (HAPLN1), which crosslinks hyaluronan to the ECM, leads to changes in the permeability of lymphatic endothelial cells, thereby enabling melanoma cells to escape from the lymphatic system to distant metastatic sites.(57) Bertero et al.”
BackgroundCurrent Molecular Markers of Melanoma and Treatment Targets
Yang, K., Oak, A. S. W., Slominski, R. M., Brożyna, A. A., & Slominski, A. T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103535 · Cited by 89
Parker, A. L., Bowman, E. D., Zingone, A., Ryan, B. M., Cooper, W. A., Kohonen‐Corish, M. R. J., Harris, C. C., & Cox, T. R. (2022) · Genome Medicine · doi:10.1186/s13073-022-01127-6 · Cited by 81
“Agerelated changes in dermal collagen architecture induced by HAPLN1 has been linked to reduced T cell motility and infiltration, and increased melanoma incidence with age [93, 95], raising the possibility that ECM remodeling represented by our matrix risk signature captures a similar process in SqCC.”
Lymphatic vessels in the age of cancer immunotherapy
Karakousi, T. R., Mudianto, T., & Lund, A. W. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00681-y · Cited by 99
Romano, V., Belviso, I., Venuta, A., Ruocco, M. R., Masone, S., Aliotta, F., Fiume, G., Montagnani, S., Avagliano, A., & Arcucci, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105283 · Cited by 83
“These data could have profound implications for the treatment and surveillance of elderly patients with melanoma [159,160].”
BackgroundRemodeling the ECM: Implications for Metastasis and Tumor Dormancy
Martino, J. S. D., Akhter, T., & Bravo‐Cordero, J. J. (2021) · Cancers · doi:10.3390/cancers13194916 · Cited by 76
“In their studies, they showed that a decrease in HAPLN1 and the remodeling of collagen in the skin during aging stimulates melanoma metastasis [80,81].”
BackgroundUnderstanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyond
Shin, E., Bak, S. H., Park, T., Kim, J.-W., Yoon, S. R., Jung, H., & Noh, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1192907 · Cited by 80
Cancer-Associated Fibroblasts: Accomplices in the Tumor Immune Evasion
Hilmi, M., Nicolle, R., Bousquet, C., & Neuzillet, C. (2020) · Cancers · doi:10.3390/cancers12102969 · Cited by 69
“Besides the direct effect on cancer cells [76], ECM-remodeling also contributes to modulation of immune cells by creating a physical immune barrier.”
BackgroundHenderson, A. R., Ilan, I. S., & Lee, E. (2021) · Microcirculation · doi:10.1111/micc.12730 · Cited by 60
Aging and homeostasis of the hypodermis in the age-related deterioration of skin function
Liu, M., Lu, F., & Feng, J. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06818-z · Cited by 79
“ECM degradation during aging differentially affects T cell subpopulations and in fi ltration [132].”
BackgroundDeterminants of resistance and response to melanoma therapy
Robertson, B. M., Fane, M. E., Weeraratna, A. T., & Rebecca, V. W. (2024) · Nature Cancer · doi:10.1038/s43018-024-00794-1 · Cited by 87
“Interestingly, this ECM reprogramming affected lymph node metastases, in which loss of HAPLN1 increased lymph endothelial cell permeability and decreased VE-cadherin, resulting in lower levels of lymph metastases but increased visceral metastases 63 .”
Self-citationDAMPs in immunosenescence and cancer
Chen, F., Tang, H., Cai, X., Lin, J., Kang, R., Tang, D., & Liu, J. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.09.005 · Cited by 67
Warner, A. B., & McQuade, J. L. (2019) · Current Oncology Reports · doi:10.1007/s11912-019-0814-2 · Cited by 63
Cancer associated fibroblast: Mediators of tumorigenesis
Alexander, J. I., & Cukierman, E. (2020) · Matrix Biology · doi:10.1016/j.matbio.2020.05.004 · Cited by 58
Cell Adhesion Molecules in Plasticity and Metastasis
Smart, J. A., Oleksak, J. E., & Hartsough, E. J. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0595 · Cited by 61
HAPLN1 potentiates peritoneal metastasis in pancreatic cancer
Wiedmann, L., Rigotti, F., Vaquero‐Siguero, N., Donato, E., Espinet, E., Moll, I., Alsina‐Sanchís, E., Bohnenberger, H., Fernández-Florido, E., Mülfarth, R. I., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38064-w · Cited by 57
The Biophysics of Lymphatic Transport: Engineering Tools and Immunological Consequences
O’Melia, M. J., Lund, A. W., & Thomas, S. N. (2019) · iScience · doi:10.1016/j.isci.2019.11.005 · Cited by 52
Cancer Response to Therapy-Induced Senescence: A Matter of Dose and Timing
Mongiardi, M. P., Pellegrini, M., Pallini, R., Levi, A., & Falchetti, M. L. (2021) · Cancers · doi:10.3390/cancers13030484 · Cited by 53
Maiques, Ó., Sallan, M. C., Laddach, R., Pandya, P., Varela-Vázquez, A., Crosas‐Molist, E., Barcelo, J., Courbot, O., Liu, Y., Graziani, V., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56299-7 · Cited by 65
Ferroptosis and immunosenescence in colorectal cancer
Wang, Y., Cao, X., Yang, C., Fan, J., Zhang, X., Wu, X., Guo, W., Sun, S., Liu, M., Zhang, L., et al. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.10.003 · Cited by 52
Fotsitzoudis, C., Koulouridi, A., Messaritakis, I., Konstantinidis, T., Gouvas, N., Tsiaoussis, J., & Souglakos, J. (2022) · Cancers · doi:10.3390/cancers14184394 · Cited by 46
Parallels of Resistance between Angiogenesis and Lymphangiogenesis Inhibition in Cancer Therapy
Jones, D. (2020) · Cells · doi:10.3390/cells9030762 · Cited by 45
“Consequently, melanoma cells avoid accumulation in tumor-draining lymph nodes but dissemination to distant sites is increased [80].”
BackgroundNormal Aging and Its Role in Cancer Metastasis
Fane, M. E., & Weeraratna, A. T. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a037341 · Cited by 45
“A follow-up to this study from our group investigated the importance of ECM breakdown on visceral metastases (Ecker et al. 2018).”
BackgroundSelf-citationMetabolic reprogramming: a bridge between aging and tumorigenesis
Drapela, S., Ilter, D., & Gomes, A. P. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13261 · Cited by 41
Ramos, R. I., Bustos, M. A., Wu, J., Jones, P. C., Chang, S., Kiyohara, E., Tran, K. D., Zhang, X., Stern, S. L., Izraely, S., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12702 · Cited by 41
CRIP1 Reshapes the Gastric Cancer Microenvironment to Facilitate Development of Lymphatic Metastasis
Wu, Z., Qu, B., Yuan, M., Liu, J., Zhou, C., Sun, M., Guo, Z., Zhang, Y., Song, Y., & Wang, Z. (2023) · Advanced Science · doi:10.1002/advs.202303246 · Cited by 40
It’s all about the base: stromal cells are central orchestrators of metastasis
Monteran, L., Zait, Y., & Erez, N. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.11.004 · Cited by 44
Chen, Y., Wang, B., Chen, Y., Wu, Q., Lai, W., Wei, L., Nandakumar, K. S., & Liu, D. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.888612 · Cited by 46
“Recently, the oncogenic phenotype of HAPLN1 was reported to be able to contribute to cellular hyperactivity and remodeling of collagen matrices (19, 20).”
BackgroundImmunosenescence and cancer: Opportunities and challenges
Fu, Z., Xu, H., Yue, L., Zheng, W., Pan, L., Gao, F., & Liu, X. (2023) · Medicine · doi:10.1097/md.0000000000036045 · Cited by 40
“[41] Elevated levels of age-related secreted frizzled-related protein 2 by fibroblasts promote angiogenesis and metastasis of melanoma.”
BackgroundTargeting Versican as a Potential Immunotherapeutic Strategy in the Treatment of Cancer
Hirani, P., Gauthier, V., Allen, C. E., Wight, T. N., & Pearce, O. M. T. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.712807 · Cited by 36
A Role for HAPLN1 During Phenotypic Modulation of Human Lung Fibroblasts In Vitro
Evanko, S. P., Gooden, M. D., Kang, I., Chan, C. K., Vernon, R. B., & Wight, T. N. (2020) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155420966663 · Cited by 34
“68(11) 797 –811 © The Author(s) 2020 Article reuse guidelines: sagepub.”
Reprogramming of tissue metabolism during cancer metastasis
Ganguly, K., & Kimmelman, A. C. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.02.005 · Cited by 36
Filipescu, D., Carcamo, S., Agarwal, A., Tung, N., Humblin, É., Goldberg, M. S., Vyas, N. S., Beaumont, K. G., Demircioğlu, D., Sridhar, S., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01208-7 · Cited by 35
Xu, Y., Benedikt, J., & Ye, L. (2024) · Cancers · doi:10.3390/cancers16101907 · Cited by 34
“HAPLN1 is also associated with peritoneal metastasis in the pancreatic cancer [107], but its expression can inhibit lymph node metastasis in melanoma [282], suggesting context-specific functionality.”
BackgroundDuan, R., Jiang, L., Wang, T., Li, Z., Yu, X., Gao, Y., Jia, R., Fan, X., & Su, W. (2024) · Nature Communications · doi:10.1038/s41467-024-55164-3 · Cited by 39
Marino, G. E., & Weeraratna, A. T. (2020) · Aging and Cancer · doi:10.1002/aac2.12013 · Cited by 31
Self-citationShannon, A. B., Sharon, C. E., Straker, R. J., Carr, M. J., Sinnamon, A. J., Bogatch, K., Thaler, A. S., Kelly, N. J., Vetto, J. T., Fowler, G., et al. (2022) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2022.09.040 · Cited by 30
Self-citationLymphatic Capillaries in Aging
Jakic, B., Kerjaschki, D., & Wick, G. (2020) · Gerontology · doi:10.1159/000508459 · Cited by 28
Marino, G. E., Carey, A. E., Hüser, L., Dixit, A., Wang, V., Kaur, A., Liu, Y., Ding, S., Schnellmann, R., Gerecht, S., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00581-8 · Cited by 29
“HUVECs were never used beyond passage 8.”
InfluentialSelf-citationThe Role of Extracellular Matrix Remodeling in Skin Tumor Progression and Therapeutic Resistance
Fromme, J. E., & Zigrino, P. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.864302 · Cited by 31
“Reduced HAPLN1 in aged skin destabilizes the ECM and perturbs VE-cadherin connections between the lymphatic endothelial cells, thus increasing permeability and promoting melanoma metastasis and extravasation from lymphatic vessels (Ecker et al., 2019).”
BackgroundMeasuring and modelling tumour heterogeneity across scales
Beeghly, G. F., Shimpi, A. A., Riter, R. N., & Fischbach, C. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00087-9 · Cited by 31
“Ageing-related changes in the bone and lymph nodes are other examples that promote distant metastasis by increasing colonization and lowering tumour-cell capture, respectively 183,184 .”
BackgroundEmerging paradigms in metastasis research
Pari, A. A. A., Singhal, M., & Augustin, H. G. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190218 · Cited by 25
“Likewise, the loss of fibroblast-secreted HAPLN1 was associated with an increased risk of distant metastasis (Ecker et al., 2019; Kaur et al., 2019).”
BackgroundCirc-0044539 promotes lymph node metastasis of hepatocellular carcinoma through exosomal-miR-29a-3p
Yang, Y., Chen, X.-Q., Jia, Y.-X., Ma, J., Xu, D., & Xiang, Z. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07004-x · Cited by 27
“In addition, we found that circ-0044539 might affect miR-29a-3p expression level in HCC cell lines in relation to culture condition, cell density, and cell doubling time (data not shown).”
Mubarok, W., Elvitigala, K. C. M. L., Nakahata, M., Kojima, M., & Sakai, S. (2022) · Cells · doi:10.3390/cells11050881 · Cited by 23
“Changes in the physicochemical properties in ECM as well as cell–ECM adhesion are also known to modulate tumor cells invasion and metastasis [55,56].”
BackgroundAged fibroblast-derived extracellular vesicles promote angiogenesis in melanoma
Hüser, L., Chhabra, Y., Gololobova, O. A., Wang, V., Liu, G., Dixit, A., Rocha, M. R., Harper, E. I., Fane, M. E., Marino, G. E., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114721 · Cited by 21
Self-citationLoss of Hyaluronan and Proteoglycan Link Protein-1 Induces Tumorigenesis in Colorectal Cancer
Wang, Y., Xu, X., Marshall, J. E., Gong, M., Zhao, Y., Dua, K., Hansbro, P. M., Xu, J., & Liu, G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.754240 · Cited by 22
“org 8 with healthy controls (32), while some other studies showed HAPLN1 levels decreased during aging, and this is potentially involved in cancer invasion (6).”
BackgroundInfluentialSelf-citationYang, Y., Wang, X., & Wang, P. (2023) · Biogerontology · doi:10.1007/s10522-023-10016-3 · Cited by 24
Dong, M., Gong, H., Li, T., Li, X., Liu, J., Zhang, H., Liu, M., Chen, G., Liu, H., & Chen, J. (2019) · Cancer Medicine · doi:10.1002/cam4.2525 · Cited by 20
Straker, R. J., Carr, M. J., Sinnamon, A. J., Shannon, A. B., Sun, J. X., Landa, K., Baecher, K. M., Wood, C., Lynch, K., Bartels, H. G., et al. (2021) · Annals of Surgical Oncology · doi:10.1245/s10434-021-10031-z · Cited by 19
Self-citationLiu, J., Zheng, R., Zhang, Y., Jia, S., He, Y., & Liu, J. (2023) · Cancers · doi:10.3390/cancers15092640 · Cited by 24
Jinna, N., Rida, P. C. G., Su, T., Gong, Z., Yao, S., LaBarge, M. A., Natarajan, R. D., Jovanović‐Talisman, T., Ambrosone, C. B., & Seewaldt, V. L. (2022) · Cells · doi:10.3390/cells11233818 · Cited by 22
“Furthermore, alterations in the tissue microenvironment during aging has been linked to metastasis in elderly cancer patients [92,93].”
BackgroundHarper, E. I., & Weeraratna, A. T. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-0505 · Cited by 20
Self-citationLiu, L., Zhang, Y., Liu, H., Yang, J., Tian, Q., Chueakula, N., Ramasamy, S. K., Verma, N. K., Cheung, C., & Kusumbe, A. P. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-4744 · Cited by 18
Lu, H., Chiu, Y.-W., Lan, W.-S., Peng, C., Tseng, H., Hsin, C., Chuang, C., Chen, C.-C., Huang, W., & Yang, S.-F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.713815 · Cited by 16
Considerations and Approaches for Cancer Immunotherapy in the Aging Host
Ontiveros, C. O., Murray, C. E., Crossland, G. E., & Curiel, T. J. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0121 · Cited by 17
Sentinel lymph nodes in melanoma: necessary as ever for optimal treatment
Faries, M. B. (2024) · Clinical & Experimental Metastasis · doi:10.1007/s10585-023-10254-2 · Cited by 18
“One potential measure of that competence can be derived during the SLN procedure, which is dependent on active uptake of radioactive tracer by antigen presenting cells located in the node [26, 27].”
BackgroundSelf-citationMahony, C. B., Pasche, C., Braunersreuther, V., Savvides, S., de Agostini, A. I., & Bertrand, J. Y. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020001524 · Cited by 20
Ji, R., lin, J. X., Gu, H., Ma, J., Fu, M., & Zhang, X. (2022) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x18666221124145847 · Cited by 14
Zhou, H., Zheng, Z., Fan, C., & Zhou, Z. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.01.001 · Cited by 22
Lymphatic transport in anti-tumor immunity and metastasis
Sun, M., Angelillo, J., & Hugues, S. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20231954 · Cited by 19
Mark, C., Warrick, J. W., Callander, N. S., Hematti, P., & Miyamoto, S. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0941 · Cited by 15
Stromal senescence contributes to age-related increases in cancer
Ye, J., Melam, A., & Stewart, S. A. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00840-9 · Cited by 18
“This in turn led to increased lymphatic permeability and increased visceral metastases of melanoma 74 (Fig.”
V3: an enigmatic isoform of the proteoglycan versican
Wight, T. N., Day, A. J., Kang, I., Harten, I. A., Kaber, G., Briggs, D. C., Braun, K. R., Lemire, J. M., Kinsella, M. G., Hinek, A., et al. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00059.2023 · Cited by 15
Unravelling the genetics and epigenetics of the ageing tumour microenvironment in cancer
Easwaran, H., & Weeraratna, A. T. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00868-x · Cited by 18
“These changes not only affect tumour cell motility but also impact immune cell trafficking and lymphatic vessel function 198,199 .”
Self-citationComparative Proteomic Analysis to Investigate the Pathogenesis of Oral Adenoid Cystic Carcinoma
Li, W., Zhang, Q., Wang, X., Wang, H., Zuo, W., Xie, H., Tang, J., Wang, M., Zeng, Z., Cai, W., et al. (2021) · ACS Omega · doi:10.1021/acsomega.1c01270 · Cited by 12
Modelling the ageing dependence of cancer evolutionary trajectories
Henry, C. J., & DeGregori, J. V. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00838-3 · Cited by 15
“…1 (HAPLN1), which cross-links hyaluronan to the ECM, mediate lymphatic endothelial permeability, thus allowing melanoma cell transit Review article through the lymphatic system to more distant metastatic sites 128 , while at the same time the aged skin ECM impedes the passage of T cells 129 .”
Zhao, J., Dong, Y., Zhang, Y., Wang, J., & Wang, Z. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114585 · Cited by 12
Pathania, S., Khan, M. I., Bandyopadhyay, S., Singh, S. S., Rani, K., Parashar, T. R., Jayaram, J., Mishra, P. R., Srivastava, A., Mathur, S. R., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-12352-9 · Cited by 9
Zhou, D., Jang, J. M., Yang, G., Ha, H. C., Fu, Z., & Kim, D. K. (2023) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2023.096 · Cited by 10
“HAPLN1 has also been known to play an important role in maintaining endothelial permeability, and its reduction in the aged microenvironment facilitates metastasis via blood vessels (Ecker et al ., 2019).”
BackgroundCarey, A. E., & Weeraratna, A. T. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108698 · Cited by 11
Self-citationComprehensive immune ageing reveals TREM2/TIM3 myeloid cells drive brain immune evasion
Segura‐Collar, B., Mondéjar-Ruescas, L., Alcivar-López, D., Garranzo‐Asensio, M., Mata-Martínez, P., García‐Escudero, R., Hernández‐Laín, A., Sepúlveda-Sánchez, J. M., Pérez‐Núñez, Á., Ávila, J., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105833 · Cited by 12
“8,9,15,26,27 There was also randomization and blinding due to the exploratory nature of the study.”
Life Factors and Melanoma: From the Macroscopic State to the Molecular Mechanism
Wang, H., Zhang, H., Zhou, Y., Li, C., & Guo, W. (2025) · Advanced Science · doi:10.1002/advs.202501388 · Cited by 10
Zhou, D., Ha, H. C., Yang, G., Jang, J. M., Park, B. K., Fu, Z., Shin, I. C., & Kim, D. K. (2023) · BMB Reports · doi:10.5483/bmbrep.2023-0088 · Cited by 8
“of HAPLN1 in the aged microenvironment promotes visceral metastasis (19).”
BackgroundEpigenetic mechanisms in melanoma development and progression
Joo, H., Olea, X. D., Zhuang, A., Zheng, B., Kim, H., & Ronai, Z. A. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.04.007 · Cited by 9
Malignant Melanoma in Older Adults: Different Patient or Different Disease?
Sasson, D. C., Smetona, J. T., Parsaei, Y., Papageorge, M. V., Ariyan, S., Olino, K. L., & Clune, J. E. (2023) · Cureus · doi:10.7759/cureus.34742 · Cited by 8
“Nodal positivity decreases with increasing age, despite the fact that tumors tend to be thicker and wider at the time of diagnosis [2,3,5-7].”
BackgroundResultKarapetyan, L., Gooding, W. E., Li, A., Yang, X., Knight, A., Abushukair, H. M., Stefano, D. V. D., Sander, C., Karunamurthy, A. D., Panelli, M. C., et al. (2022) · Cancers · doi:10.3390/cancers14204973 · Cited by 7
“Age-related increases in lymphatic permeability due to stromal changes associated with hyaluronan and proteoglycan link protein 1 loss may increase false-negative SLN biopsy rates [7].”
BackgroundAge-related transcriptome changes in melanoma patients with tumor-positive sentinel lymph nodes
Menefee, D. S., McMasters, A., Pan, J., Li, X., Xiao, D., Waigel, S. J., Zacharias, W., Rai, S. N., McMasters, K. M., & Hao, H. (2020) · Aging · doi:10.18632/aging.202435 · Cited by 8
Lymphatic Transport Efficiency Determines Metastatic Potential of Cutaneous Melanoma
Holder, A. M., & Žiemys, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01607 · Cited by 7
“has proposed that changes in the lymphatic extracellular matrix occur during the aging process that may alter lymphatic permeability allowing metastatic disease to escape from the lymphatic system and directly enter the hematogenous system resulting in visceral or distant metastases (12).”
BackgroundRole of cancer-associated fibroblasts in tumor microenvironment
Mir, M. A., Sofi, S., & Aisha, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-443-18696-7.00002-6 · Cited by 6
Metadata
- Authors
- Ecker, B. L., Kaur, A., Douglass, S. M., Webster, M. R., Almeida, F. V., Marino, G. E., Sinnamon, A. J., Neuwirth, M. G., Alicea, G. M., Ndoye, A., Fane, M., Xu, X., Sim, M. S., Deutsch, G. B., Faries, M. B., Karakousis, G. C., & Weeraratna, A. T.
- Affiliations
- The Wistar Institute (US)
- University of Pennsylvania (US)
- University of California, Los Angeles (US)
- Northwell Health (US)
- Angeles Clinic and Research Institute (US)
- Corresponding author
- Weeraratna, Ashani T.
- ORCID
- Venue
- Cancer Discovery
- Published
- 2019-01-01
- Volume
- 9
- Issue
- 1
- Pages
- 82-95
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- PMC
- PMC6328344
- OpenAlex
- W2895129523
- Cited by
- 153
- References
- 30
- Citations by year
- 2026: 14 · 2025: 18 · 2024: 21 · 2023: 24 · 2022: 23 · 2021: 16 · 2020: 28 · 2019: 8
- FWCI
- 4.97
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Discovery (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- HHS | NIH | National Cancer Institute (NCI) (R01CA174746, R01CA207935, P01 CA114046, P50 CA174523, K99 CA208012, P30CA010815)
- Melanoma Research Alliance (MRA) (N/A)
- Melanoma Research Foundation (MRF) (N/A)
- Wistar Science Discovery Fund (N/A)
- Topics
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Health Sciences › Medicine › Surgery › Lymphatic Disorders and Treatments
- Keywords
- HAPLN1, melanoma metastasis, aging, lymphatic permeability, sentinel lymph node biopsy, technetium-99m, extracellular matrix degradation, VE-cadherin, tumor microenvironment, visceral metastases, prognostic factors, stroma
- MeSH terms
- Proteoglycan Link Protein, Adult, Aging, Animals, Cells, Cultured, Humans, Immune System, Lymphatic Metastasis, Melanoma, Mice, Inbred C57BL, Middle Aged, Proteoglycans, Skin, Extracellular Matrix Proteins, Mice, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.